ID   UKF-NB-6rVCR10
AC   CVCL_M477
SY   UKF-NB-6 VCR
DR   Wikidata; Q54990402
RX   PubMed=17505515;
RX   PubMed=24466371;
RX   PubMed=27735941;
WW   https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
RX   PubMed=17505515; DOI=10.1038/sj.bjc.6603777;
RA   Blaheta R.A., Michaelis M., Natsheh I., Hasenberg C., Weich E.,
RA   Relja B., Jonas D., Doerr H.-W., Cinatl J. Jr.;
RT   "Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant
RT   neuroblastoma tumour cells to endothelium.";
RL   Br. J. Cancer 96:1699-1706(2007).
//
RX   PubMed=24466371; DOI=10.1593/tlo.13544;
RA   Loschmann N., Michaelis M., Rothweiler F., Zehner R., Cinatl J.,
RA   Voges Y., Sharifi M., Riecken K., Meyer J., von Deimling A.,
RA   Fichtner I., Ghafourian T., Westermann F., Cinatl J. Jr.;
RT   "Testing of SNS-032 in a panel of human neuroblastoma cell lines with
RT   acquired resistance to a broad range of drugs.";
RL   Transl. Oncol. 6:685-696(2013).
//
RX   PubMed=27735941; DOI=10.1038/cddis.2016.257;
RA   Voges Y., Michaelis M., Rothweiler F., Schaller T., Schneider C.,
RA   Politt K., Mernberger M., Nist A., Stiewe T., Wass M.N., Rodel F.,
RA   Cinatl J. Jr.;
RT   "Effects of YM155 on survivin levels and viability in neuroblastoma
RT   cells with acquired drug resistance.";
RL   Cell Death Dis. 7:e2410.1-e2410.11(2016).
//